Vermont Healthcare Center: Missed Thyroid Doses - CA
The inspection, completed March 14, 2025, found that Resident 361, a woman with a thyroid disorder, had two doses of Liothyronine go unadministered, on March 1 and March 6. Liothyronine is a thyroid hormone replacement. Missing doses can cause hypothyroidism and constipation, according to the licensed vocational nurse who reviewed the records with inspectors.
Resident 361's care plan, initiated February 27, 2025, set a goal that she would be free from weakness and tiredness daily for three months. The interventions listed to achieve that goal included administering her medications as ordered and monitoring her for exactly those symptoms. The doses were missed anyway.
When inspectors sat down with Resident 361 on March 11, she said it plainly: she does not always receive her thyroid medications in the morning.
The next day, inspectors reviewed her Medication Administration Record alongside Licensed Vocational Nurse 1. The MAR is the daily log a nurse uses to document what medications a resident actually received. Two entries for Liothyronine were blank. Inspectors also examined the physical bubble pack, the sealed medication packaging that shows which doses have been pushed out and which remain. Two doses were still there, untouched.
LVN 1 told inspectors she was the nurse assigned to Resident 361 on March 6. She said she was not sure how she missed that medication.
That answer, "not sure," is the detail that tends to stay with families. Not that a nurse made a deliberate choice to skip a medication. Not that there was a shortage or a system failure anyone could point to. Just that a medication a resident depended on, one tied directly to whether she would feel weak or tired, simply did not get administered, and the person responsible for giving it could not account for why.
The facility's own medication administration policy states that medications must be given in accordance with physician orders, including any required time frame. Liothyronine is typically ordered for once-daily morning administration because thyroid hormone levels are sensitive to timing. The care plan reflected that. The MAR reflected it. The bubble pack reflected it. What the records did not reflect was anyone catching the missed doses before Resident 361 brought it up to an inspector herself.
CMS rated the level of harm as minimal harm or potential for actual harm, the lower end of the deficiency scale. The violation was tagged as affecting many residents, a designation that reflects the scope of the problem across the facility rather than the number of residents with confirmed missed doses documented in this particular finding.
Vermont Healthcare Center is located at 22035 S. Vermont Avenue in Torrance. The inspection was conducted by the California Department of Public Health on behalf of the Centers for Medicare and Medicaid Services.
The care plan written for Resident 361 in late February described a straightforward goal: no weakness, no tiredness, for three months. By March 1, the first dose had already been missed. By March 6, the second. Resident 361 noticed. She told an inspector. The bubble pack still held the evidence.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Vermont Healthcare Center from 2025-03-14 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: November 18, 2026 · Our methodology
VERMONT HEALTHCARE CENTER in TORRANCE, CA was cited for violations during a health inspection on March 14, 2025.
Liothyronine is a thyroid hormone replacement.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.
